Trial Profile
Effect of Dexmedetomidine on Pacemaker Function Following Cardiac Surgery
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 02 Apr 2019
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary)
- Indications Cancer pain; Pain; Sedation
- Focus Pharmacodynamics
- 27 Mar 2019 Planned End Date changed from 1 Dec 2019 to 11 Mar 2019.
- 27 Mar 2019 Planned primary completion date changed from 1 Dec 2019 to 11 Mar 2019.
- 27 Mar 2019 Status changed from recruiting to withdrawn prior to enrolment.